2017 Highlights

Last Year at Life Sciences Future:

LSF 2017:


 

Schedule Highlights

Company Reverse Pitch Presentations
AstraZeneca
B. Braun
Bristol-Myers Squibb
CSL Behring
DSM
GSK
Johnson&Johnson Innovation
Merck
Pfizer
Shire
Teleflex
Teva

Company Presentations
Carma Therapeutics
ConverGene
GenPro
LifeCuff Technologies
Oncoceutics
QR Pharma
Quantitative Radiology Solutions (QRS)
Recensa Therapeutics
Renerva
Sen-Jam
SFA Therapeutics
Sonavex
Trovita Health Science
Wellesley Pharmaceuticals
Yiviva

Funding Meet-ups
1315 Capital
Aisling Capital
Ben Franklin Technology Partners of Northeastern PA
Binational Industrial Research and Development Foundation
BioAdvance
BioMotiv
Capgenic Advisors
Domain Associates
Dreamit
F-Prime Capital Partners
IP Group
Life Sciences Greenhouse of Central PA
MVP Capital Partners
OrbiMed Healthcare Fund Management
Pittsburgh Life Sciences Greenhouse
SR-One
Velocity

LSF Testimonials

“The sessions were outstanding and much appreciated by the faculty, administrators, and students who attended.”

– Dr. Helen F. Giles-Gee President,University of the Sciences

Life Sciences Future was one of the most productive, informative and educational events I have been to in a while. The format and content of the conference was spot-on.”

– Marc S. Malandro Ph.D., Associate Vice Chancellor for Technology Management and Commercialization, University of Pittsburgh

Life Sciences Future was a fantastic opportunity to meet with a wide range of contacts and potential partners in the Pennsylvania Life Sciences industry. We look forward to continuing to benefit from the great networking opportunities afforded by Life Sciences PA.”

-Kevin Elliott, IDA Ireland

“The location, the layout, the right mix of people and the timing were all well thought out. I thought the conference was great.”

– Rudy Treichel, Director of Graduate Programs, Widener University

“I found the Life Sciences Future Partnering System extremely beneficial and useful organizing more than 9 meetings with life science professionals throughout the day. Equally was outstanding the support from the Life Sciences PA team.”

– Renay A Ebelle, President & CEO, Ebelle D’Ebelle Pharmaceuticals, Inc.